AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Xilio Therapeutics, Inc.
$8.03
-$1.37 (-14.57%)
Previous Close
$7.77
Day Range
$7.05$8.14
Year Range
$6.47$12.32
Market Cap
52.84M
AVG Volume
22.78K
Trailing/Forward PE
-5.39/-
PEG ratio
0.09
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: XLO
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.
Video analysis: XLO
All videosNo video analysis for this stock yet. Request one from our team.
News: XLO
Similar companies
-
PDS Biotechnology Corporation
PDSB
·
NASDAQ
Compare
-
Actinium Pharmaceuticals, Inc.
ATNM
·
New York Stock Exchange Arca
Compare
-
Tempest Therapeutics, Inc.
TPST
·
NASDAQ
Compare
-
OnKure Therapeutics, Inc.
OKUR
·
NASDAQ
Compare
-
Skye Bioscience, Inc.
SKYE
·
NASDAQ
Compare
-
Tvardi Therapeutics, Inc.
TVRD
·
NASDAQ
Compare